Wave Life Sciences (WVE) Competitors

Wave Life Sciences (NASDAQ:WVE) and Cytokinetics (NASDAQ:CYTK) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment.

Is WVE or CYTK more profitable?

Wave Life Sciences has a net margin of -66.50% compared to Cytokinetics' net margin of -17,906.25%. Cytokinetics' return on equity of 0.00% beat Wave Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wave Life Sciences	-66.50%	-280.57%	-52.90%
Cytokinetics	-17,906.25%	N/A	-50.21%

Do analysts prefer WVE or CYTK?

Wave Life Sciences presently has a consensus price target of $20.50, indicating a potential upside of 185.12%. Cytokinetics has a consensus price target of $70.92, indicating a potential upside of 114.20%. Given Wave Life Sciences' higher probable upside, equities analysts plainly believe Wave Life Sciences is more favorable than Cytokinetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wave Life Sciences	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
Cytokinetics	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93

Does the media favor WVE or CYTK?

In the previous week, Cytokinetics had 9 more articles in the media than Wave Life Sciences. MarketBeat recorded 20 mentions for Cytokinetics and 11 mentions for Wave Life Sciences. Wave Life Sciences' average media sentiment score of 1.11 beat Cytokinetics' score of 0.35 indicating that Wave Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wave Life Sciences	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cytokinetics	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation & earnings, WVE or CYTK?

Wave Life Sciences has higher revenue and earnings than Cytokinetics. Wave Life Sciences is trading at a lower price-to-earnings ratio than Cytokinetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wave Life Sciences	$104.94M	10.56	-$57.51M	-$0.84	-8.56
Cytokinetics	$19.22M	205.76	-$526.24M	-$5.29	-6.26

Does the MarketBeat Community favor WVE or CYTK?

Cytokinetics received 462 more outperform votes than Wave Life Sciences when rated by MarketBeat users. Likewise, 79.83% of users gave Cytokinetics an outperform vote while only 67.83% of users gave Wave Life Sciences an outperform vote.

Company	Underperform	Outperform
Wave Life Sciences	Outperform Votes 369 67.83%	Underperform Votes 175 32.17%
Cytokinetics	Outperform Votes 831 79.83%	Underperform Votes 210 20.17%

Which has more volatility & risk, WVE or CYTK?

Wave Life Sciences has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500. Comparatively, Cytokinetics has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of WVE or CYTK?

89.7% of Wave Life Sciences shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by insiders. Comparatively, 2.7% of Cytokinetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Cytokinetics beats Wave Life Sciences on 10 of the 19 factors compared between the two stocks.